The role of contrast-enhanced ultrasound in the diagnostic assessment of renal masses. Efficacy and clinical implications

Nº de DOI: 10.34896/RSI.2025.20.15.001

AUTHORS

1. Karen Mishell Santamaria Salazar. General Practitioner. Master in Occupational Health and Safety. Attached to the José Carrasco Arteaga Hospital. Independent Researcher of the Research and Teaching Department Matilde Hidalgo of Procel. Graduated from the Technical University of Ambato. (Cuenca-Ecuador). https://orcid.org/0009-0003-4000-1980
2. Valeria Valentina Satama Andrade. General Practitioner. Attached to Casa Cuna Gangotena Health Center. Graduated from the National University of Loja. (⁠Quito-Ecuador). https://orcid.org/0009-0003-0213-8492
3. Pablo Andres Montaño Ucho. General Practitioner. Attached to the Pablo Jaramillo Crespo Humanitarian Hospital Foundation. Graduated from the University of Cuenca. (⁠Cuenca-Ecuador). https://orcid.org/0009-0008-5216-3561
4. María José Bravo Cofre. General Practitioner. Attached to Private Clinics of Ecuador. Graduated from the University of Guayaquil. (⁠Guayaquil-Ecuador). https://orcid.org/0009-0004-4737-4410
5. Carlos Alejandro Rojas Merchán. General Practitioner. Attached to Private Clinics of Ecuador. Graduated from the Catholic University of Cuenca. (Azogues-Ecuador). https://orcid.org/0000-0003-2313-4901
6. Bryan Adrián Espin Taguada. General Practitioner. Attached to Mediqx. Graduated from the Central University of Ecuador (Quito-Ecuador). https://orcid.org/0000-0003-0981-5372

ABSTRACT

This paper aims to provide a comprehensive overview of the role of CEUS in the diagnostic assessment of renal masses, highlighting its efficacy, clinical implications, and the barriers that must be addressed to optimize its use in practice.

KEY WORDS

Contrast-enhanced ultrasound, renal masses, diagnostic accuracy, renal cancer imaging and contrast-enhanced ultrasound clinical applications.

RESUMEN

Este artículo tiene como objetivo proporcionar una visión general completa del papel de la CEUS en la evaluación diagnóstica de las masas renales, destacando su eficacia, sus implicaciones clínicas y las barreras que se deben abordar para optimizar su uso en la práctica.

PALABRAS CLAVE

Ultrasonido con contraste, masas renales, precisión diagnóstica, imágenes de cáncer renal y aplicaciones clínicas del ultrasonido con contraste.

INTRODUCTION

In recent years, the advancement of imaging technologies has significantly transformed the diagnostic landscape in renal medicine, with Contrast-Enhanced Ultrasound (CEUS) emerging as a pivotal tool in the assessment of renal masses. CEUS operates on the fundamental principles of enhancing the echogenicity of blood flow within tissues through the use of microbubble contrast agents, thereby providing a more detailed visualization compared to traditional ultrasound techniques, which often lack the sensitivity required for accurate diagnosis. Unlike conventional modalities such as computed tomography (CT) and magnetic resonance imaging (MRI), CEUS offers real-time imaging without the use of ionizing radiation, making it a safer alternative, particularly for vulnerable populations. The diagnostic efficacy of CEUS in evaluating renal masses has been underscored by its ability to significantly enhance the identification of lesions, with reported sensitivity and specificity rates that rival those of established imaging techniques. Moreover, CEUS has demonstrated a robust capacity to differentiate between benign and malignant renal lesions, facilitating more informed clinical decision-making and management strategies. The clinical implications of incorporating CEUS into renal mass assessment are substantial, as it not only improves patient outcomes through timely and accurate diagnoses but also minimizes the need for invasive procedures. However, despite its advantages, CEUS is not without limitations; factors such as operator dependence and the technical challenges associated with its implementation can impact diagnostic accuracy. Therefore, understanding the current limitations and exploring future advancements become crucial in maximizing the potential of CEUS in renal diagnostics.

OBJECTIVE

To provide an overview of the role of contrast-enhanced ultrasound in the diagnostic evaluation of renal masses, highlighting its efficacy, its clinical implications and the obstacles that need to be addressed to optimise its use in practice.

METHODOLOGY

This scientific review follows a structured approach to analyze the role of contrast-enhanced ultrasound (CEUS) in the diagnostic assessment of renal masses, focusing on its efficacy and clinical implications. The study relies on a comprehensive literature review of peer-reviewed articles, clinical trials, and meta-analyses published in medical and radiology journals. Databases such as PubMed, Scopus, and Web of Science are systematically searched using keywords including «contrast-enhanced ultrasound», «renal masses», «diagnostic accuracy», «renal cancer imaging» and «Contrast-enhanced ultrasound clinical applications”. Studies published within the last two decades are prioritized to ensure relevance to current clinical practices and technological advancements.

Inclusion criteria for selected articles consist of studies evaluating the sensitivity, specificity, and predictive value of CEUS in detecting and characterizing renal masses, as well as comparative analyses with other imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). Case studies, systematic reviews, and expert consensus reports are also considered to provide a comprehensive perspective on clinical decision-making. Exclusion criteria include studies with limited sample sizes, outdated methodologies, and those lacking quantitative data on CEUS performance.

The collected data are analyzed to assess the advantages and limitations of CEUS in renal mass characterization, particularly in distinguishing benign from malignant lesions. Special attention is given to factors such as lesion enhancement patterns, perfusion characteristics, and the ability of CEUS to detect microvascular flow in real-time. The review also explores the clinical implications of CEUS, including its role in guiding biopsy procedures, reducing the need for nephrectomy, and improving patient management strategies.

Ethical considerations are maintained by ensuring that all included studies adhere to ethical research guidelines and institutional approvals. The findings are synthesized to provide a comprehensive overview of CEUS as a diagnostic tool for renal masses, highlighting gaps in current knowledge and suggesting directions for future research.

RESULTS

Overview of Contrast-Enhanced Ultrasound (CEUS) Technology

What are the fundamental principles of CEUS?

A fundamental principle of Contrast-Enhanced Ultrasound (CEUS) is its reliance on ultrasonographic contrast agents (UCAs), particularly microbubbles, which are crucial for enhancing the reflection of ultrasound waves^1,2. These microbubbles have a high degree of echogenicity, which significantly improves the contrast of the sonogram by leveraging the difference in echogenicity between the microbubbles and the surrounding tissues². One of the most sophisticated techniques employed in CEUS is the pulse-inversion technique, which involves emitting two ultrasound pulses that are identical in amplitude and frequency but differ in phase by 180°¹. This method allows for the suppression of signals from static tissues while selectively visualizing microbubbles, as the second pulse cancels out the first when reflected by these static tissues, while microbubbles produce harmonic frequencies that are effectively captured by the transducer¹. The ability of current ultrasound machines to differentiate between the frequencies generated by the UCAs and those from static tissues further underscores the technological advancements that support CEUS [1]. Such advancements emphasize the necessity for physicians to familiarize themselves with these basic principles to accurately interpret findings and avoid potential misdiagnoses¹. Consequently, a deep understanding of these principles is essential for the effective application and optimization of CEUS, ensuring high-quality diagnostic performance and maximizing its utility across various vascular applications^3,4.

How does CEUS differ from traditional ultrasound techniques?

One of the significant distinctions between CEUS and traditional ultrasound techniques lies in the safety and efficacy of the contrast agents used. CEUS employs ultrasound contrast agents (UCAs), such as SonoVue™, which consist of microbubbles that enhance the echogenicity of blood, providing clearer and more detailed images of vascular structures⁵. These microbubbles are particularly beneficial as they remain intravascular, thereby offering a dynamic assessment of blood flow on both macro- and microvascular scales without the inherent risks associated with ionizing radiation or the use of potentially harmful contrast agents, such as iodinated or gadolinium-based compounds found in other imaging modalities⁵. This enhanced imaging capability allows CEUS to offer superior diagnostic insights, especially in characterizing focal liver lesions and other conditions, thus proving its efficacy over conventional ultrasound methods that do not utilize contrast agents⁵. The ability to perform CEUS at the bedside is another advantage, making it a valuable tool in settings where patient mobility is a concern, such as in intensive care units⁵. As CEUS continues to gain acceptance through further approvals and guideline developments, its distinction from traditional ultrasound techniques becomes increasingly apparent, necessitating broader implementation and expertise in clinical practice.

What are the key components and agents used in CEUS?

The core components of CEUS revolve around the integration of ultrasound technology with specialized contrast agents, primarily containing microbubbles, to improve the clarity and detail of internal imaging⁶. These microbubbles play a crucial role in enhancing the imaging process, as they produce bright echoes that significantly enhance the depiction of both macrovascular and microvascular structures within the body⁴. This advancement allows for dynamic visualization of vascular phases, particularly beneficial when examining organs like the liver, where the arterial, portal venous, and late phases can be distinctly observed³. The utilization of ultrasound contrast agents (UCAs) also facilitates real-time recording and evaluation, which is essential for capturing detailed images over time, such as the wash-in and wash-out phases that occur over several minutes³. This intricate process not only augments the diagnostic accuracy of CEUS but also positions it as a viable substitute for more invasive imaging modalities like CT scans or MRIs, especially for evaluating the liver, kidneys, or bladder⁷. Consequently, the effective amalgamation of these key components and agents in CEUS underscores its pivotal role in advancing medical imaging, necessitating continued innovation and optimization to enhance its application across diverse clinical settings.

Diagnostic Efficacy of CEUS in Evaluating Renal Masses

How does CEUS improve the identification of renal masses compared to other imaging modalities?

Contrast-enhanced ultrasound (CEUS) significantly enhances the identification and characterization of renal masses by providing real-time insights into vascularity and perfusion dynamics, which are crucial for distinguishing between benign and malignant lesions⁸. Unlike traditional imaging modalities such as CT and MRI, CEUS employs microbubble contrast agents that do not interfere with the renal collection system, facilitating clearer enhancement patterns and more precise lesion characterization⁹. This capability is particularly beneficial for small and indeterminate renal masses, where CEUS offers superior sensitivity and specificity compared to other imaging techniques, thus improving diagnostic accuracy and reducing the necessity for additional imaging examinations⁸. Moreover, CEUS can be performed at the bedside, making it suitable for patients who are intolerant to conventional imaging methods, including pediatric patients and those with compromised renal function⁹. By providing a cost-effective, rapid, and accurate diagnostic alternative, CEUS plays a pivotal role in clinical decision-making and can significantly alleviate the need for invasive procedures such as biopsies or surgical interventions by confirming benign lesions⁹. As advancements continue to enhance its diagnostic capabilities, CEUS is poised to establish itself as a reliable and indispensable tool in the routine evaluation of renal masses⁸.

What are the sensitivity and specificity rates of CEUS in renal mass detection?

In the context of renal mass detection, Contrast-Enhanced Ultrasound (CEUS) demonstrates a high sensitivity rate, making it a valuable tool for identifying malignancies within kidney lesions¹⁰. The sensitivity of CEUS is reported to be 0.94 when distinguishing between malignant and benign small renal masses (SMRs), underscoring its effectiveness in detecting possible malignancies¹¹. This high sensitivity is particularly advantageous in clinical scenarios involving patients with chronic kidney disease or those who have contraindications to other contrast agents, as CEUS can serve as a reliable imaging test to rule out malignancy¹⁰. However, the specificity of CEUS, which measures its ability to correctly identify non-malignant lesions, is notably lower, recorded at 0.78 for distinguishing between malignant and benign SMRs¹¹. This lower specificity indicates a significant number of false positives, where positive results may not necessarily confirm the presence of disease¹⁰. Due to this, while CEUS is adept at ruling out malignancy, it is less effective at confirming it, which calls for potential modifications in its classification scheme to enhance specificity¹⁰. Thus, while CEUS presents itself as a promising diagnostic tool due to its high sensitivity, further refinement in its application is crucial for improving its specificity and overall diagnostic accuracy.

In what ways does CEUS assist in differentiating between benign and malignant renal lesions?

The utility of Contrast-enhanced ultrasound (CEUS) in differentiating between benign and malignant renal lesions is underscored by its ability to evaluate various imaging features that are critical for accurate diagnosis. CEUS has shown remarkable effectiveness in identifying malignant renal lesions, as evidenced by its success in detecting 83 out of 86 clear cell renal cell carcinoma (ccRCC) cases, highlighting its proficiency in recognizing malignancy¹². This capability is further supported by its high sensitivity of 95%, which underscores CEUS’s reliability in malignancy detection⁹. Moreover, the technique’s specificity at 80% demonstrates its competence in correctly identifying benign lesions to some extent, although challenges such as distinguishing lipid-poor angiomyolipoma (AML) from ccRCC and oncocytoma from chromophobe RCC (ChRCC) remain significant obstacles^9,12. Despite these challenges, CEUS’s ability to predict malignant lesions through the analysis of hyperenhancement and wash-out characteristics provides crucial diagnostic insights⁹. The differentiation of tumors using CEUS is further enhanced by considering tumor size, as the features of renal tumors vary based on this parameter, necessitating its integration into the assessment process¹². Overall, while CEUS is a valuable tool in differentiating renal lesions, continued refinement in its application and consideration of limitations are necessary to optimize its diagnostic accuracy and clinical utility.

Clinical Implications of CEUS in Renal Mass Assessment

How does CEUS impact clinical decision-making in managing renal masses?

The application of Contrast-Enhanced Ultrasound (CEUS) in the management of renal masses has revolutionized clinical decision-making due to its high diagnostic accuracy and non-invasive nature. CEUS provides a significant advantage in differentiating between benign and malignant renal lesions, which is critical in determining appropriate treatment strategies for localized renal masses^13,14. This level of diagnostic precision is particularly beneficial when evaluating small renal masses, where traditional imaging methods may fall short. Ongoing advancements in CEUS technology and imaging protocols further enhance its diagnostic capabilities, allowing clinicians to make more informed decisions by providing real-time insights into lesion vascularization and perfusion characteristics¹³. Additionally, CEUS’s ability to evaluate the enhancement curve over time aids in distinguishing between different subtypes of renal cell carcinoma, such as clear cell RCC, papillary RCC, and chromophobe RCC, thereby refining clinical management plans and potentially averting unnecessary surgical interventions¹⁵. As CEUS continues to demonstrate superior sensitivity compared to other imaging modalities, its integration into routine practice could significantly optimize treatment pathways and improve patient outcomes, underscoring the need for further validation studies to solidify its role in clinical settings¹³.

What are the benefits of using CEUS in terms of patient outcomes and safety?

The benefits of using Contrast-Enhanced Ultrasound (CEUS) in terms of patient outcomes and safety are multifaceted, enhancing both diagnostic and therapeutic processes. One of the core advantages is its intraprocedural application, which significantly impacts patient outcomes by reducing the necessity for additional treatments. CEUS allows for the detection of incomplete ablation immediately after radiofrequency ablation (RFA), thus enabling re-treatment within the same session. This has been shown to avoid the need for a second treatment session in 31.1% of patients, thereby not only improving medical outcomes but also minimizing patient stress and potential complications from multiple procedures¹⁶. Furthermore, the use of CEUS is safer than many other diagnostic imaging options as it does not involve ionizing radiation, which is particularly beneficial for patient safety, especially in populations requiring frequent imaging such as pediatric patients or those with renal¹⁷. Additionally, CEUS is effective in a wide range of clinical scenarios, from bedside evaluations to complex surgical interventions, offering convenience and accessibility that can streamline patient management and facilitate timely medical interventions¹⁷. The integration of CEUS into clinical practice thus not only optimizes therapeutic outcomes through precise real-time imaging but also enhances safety and comfort for patients, underscoring the necessity of its broader adoption in medical protocols¹⁸.

In what clinical scenarios is CEUS most advantageous for renal mass evaluation?

CEUS stands out for its diagnostic value in evaluating small renal masses, where conventional methods might fall short [19]. Particularly, CEUS demonstrates superior diagnostic efficacy in distinguishing between renal cell carcinoma (RCC) and angiomyolipoma (AML), two conditions with distinct perfusion characteristics that may appear similar on conventional ultrasound¹⁹. In RCC evaluation, CEUS reveals a «fast-in and fast-out» contrast enhancement mode, indicative of the tumor’s higher degrees of perfusion, which is a crucial detail for clinicians when assessing the aggressiveness of a lesion²⁰. Conversely, CEUS characterizes AML with a «slow-in and slow-out» enhancement mode, aiding in its differentiation from RCC²⁰. These distinct perfusion patterns provide a non-invasive and effective means to not only identify but also to understand the nature of renal masses, thereby enhancing confidence in clinical decision-making²¹. Moreover, CEUS is advantageous for patients who cannot undergo contrast-enhanced computed tomography (CECT) or MRI due to contraindications, thus serving as a reliable alternative for identifying suspicious renal masses²¹. This attribute underscores the versatility of CEUS and its potential to fill gaps left by other imaging modalities, ensuring comprehensive renal mass evaluation without compromising patient safety.

Limitations and Challenges of CEUS in Renal Diagnostics

What are the current limitations of CEUS in renal imaging?

One of the primary limitations of Contrast-Enhanced Ultrasound (CEUS) in renal imaging is its difficulty in identifying small lesions, which is a challenge shared with other imaging modalities such as MRI and CT²². This limitation is further compounded by the fast perfusion process observed in the arterial phase, particularly in small, richly vascularized tumors, making it challenging to accurately delineate tumor perfusion¹⁵. Additionally, CEUS falls short in assessing blood vessel morphology, which is crucial for effective diagnosis, especially when evaluating complex renal pathologies¹⁵. This deficiency in capturing detailed time resolution and vascular details limits CEUS’s diagnostic efficacy compared to more advanced imaging techniques like CT, which remains the preferred modality for certain evaluations, including the staging of malignant renal lesions²³. To overcome these limitations, a more integrated imaging approach that combines CEUS with other modalities may be necessary, providing a more comprehensive diagnostic tool that leverages the strengths of each technique.

How do technical and operator-dependent factors affect CEUS results?

The impact of both technical and operator-dependent factors on CEUS results cannot be overstated, as these variables collectively determine the quality and accuracy of the imaging outcomes. Operator expertise is a pivotal element, as the skill level directly influences the clarity and accuracy of the images obtained during CEUS procedures²⁴. This is particularly evident when examining complex anatomical structures, such as carotid arteries, where inexperienced operators may struggle to capture clear images, potentially affecting diagnostic accuracy²⁴. The operator’s ability to interpret and classify findings also plays a crucial role, especially in contexts like the Bosniak classification for renal cysts, where the prediction of malignancy requires precise operator input based on patient factors²⁵. Moreover, the technical aspects, such as the dosage and type of UCA used, are critical in ensuring optimal image enhancement and avoiding artifacts that could mislead interpretations²⁶. These factors highlight the importance of comprehensive training and experience in both technical execution and interpretative accuracy to harness the full potential of CEUS as a diagnostic tool. Ensuring that operators are well-trained and that technical protocols are meticulously followed is essential to achieve consistent and reliable results in clinical settings.

What future advancements are needed to enhance the efficacy of CEUS?

To build on the existing advantages of contrast-enhanced ultrasound (CEUS), future advancements are crucial for enhancing its efficacy in clinical practice. A primary area of focus should be the development of improved contrast agents, as these are fundamental to the performance of CEUS. Enhanced contrast agents can increase the sensitivity and specificity of the imaging process, thereby improving diagnostic accuracy and patient care²⁷. Additionally, integrating artificial intelligence for the automated analysis and interpretation of CEUS images is expected to significantly boost its efficiency and precision²⁷. This technological integration would not only streamline the diagnostic process but also facilitate a more standardized approach across different healthcare settings. Furthermore, collaborative initiatives are necessary to establish guidelines and optimize imaging parameters, ensuring consistency in image acquisition and interpretation²⁷. Such collective efforts can address current barriers and push the boundaries of CEUS, transforming it into an indispensable tool in various clinical environments²⁷. Ultimately, these advancements will be instrumental in expanding the applications of CEUS, thereby enhancing its overall efficacy²⁷.

DISCUSSION

The findings of this research highlight the transformative potential of Contrast-Enhanced Ultrasound (CEUS) in the diagnostic assessment of renal masses, underscoring its superiority over traditional imaging modalities. The use of ultrasonographic contrast agents, particularly microbubbles, allows for enhanced visualization of renal vasculature and perfusion dynamics, which is critical for accurate differentiation between benign and malignant lesions. This capability is particularly significant in the context of small renal masses, where traditional imaging often falls short, and where misdiagnosis can lead to overtreatment or delayed intervention. Furthermore, the bedside applicability of CEUS enhances its clinical utility, especially for patients with mobility limitations or those unable to tolerate other imaging techniques due to contraindications. However, while CEUS demonstrates high sensitivity in detecting malignancies, its lower specificity necessitates a cautious interpretation of results, particularly in cases with overlapping imaging characteristics. These limitations emphasize the need for ongoing training and adherence to technical protocols among operators to ensure consistent and reliable outcomes. Future research should focus on refining CEUS techniques, including the development of more advanced contrast agents and the integration of artificial intelligence for enhanced image analysis. Such advancements could facilitate a more nuanced understanding of renal mass characteristics and further improve diagnostic accuracy. Collaborative efforts to establish standardized guidelines for CEUS implementation in clinical practice are crucial for maximizing its benefits. Ultimately, while CEUS represents a significant advancement in renal imaging, a balanced approach that considers its limitations alongside its advantages will be essential in optimizing patient care and management strategies moving forward.

CONCLUSIONS

1. Contrast-enhanced ultrasound (CEUS) has emerged as a valuable diagnostic tool for assessing renal masses, offering high sensitivity and specificity in differentiating benign from malignant lesions. This review highlights the advantages of CEUS, including its real-time imaging capabilities, absence of nephrotoxic contrast agents, and superior detection of microvascular flow, making it particularly beneficial for patients with renal insufficiency or those contraindicated for contrast-enhanced CT or MRI. The ability of CEUS to provide detailed perfusion characteristics of renal lesions enhances diagnostic accuracy and supports clinical decision-making in managing renal tumors.
2. Compared to traditional imaging modalities, CEUS demonstrates significant potential in reducing the need for invasive procedures such as biopsies and unnecessary nephrectomies, contributing to more conservative and personalized treatment approaches. Furthermore, its dynamic imaging properties allow for improved lesion characterization, aiding in distinguishing complex cystic lesions from solid malignancies. Despite these advantages, challenges remain, including operator dependency, limited availability in some clinical settings, and the need for standardized interpretation criteria to ensure consistency across healthcare institutions.
3. The clinical implications of CEUS extend beyond initial diagnosis, as it also plays a role in post-treatment surveillance and guiding interventional procedures. Given its non-ionizing nature and cost-effectiveness, CEUS has the potential to be integrated more widely into routine nephrology and oncology practice. However, further large-scale studies and randomized controlled trials are necessary to establish standardized CEUS protocols, refine its diagnostic algorithms, and confirm its long-term efficacy in renal mass evaluation.

REFERENCES

1. Rafailidis V, Li X, Sidhu PS, Partovi S, Staub D. Contrast imaging ultrasound for the detection and characterization of carotid vulnerable plaque. Cardiovascular Diagnosis and Therapy [Internet]. 2020 Aug [cited 2020 Dec 18];10(4):965–81. Available from: Dx.doi.org/10.21037/cdt.2020.01.08
2. Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, et al. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012. Ultrasound in Medicine & Biology [Internet]. 2013 Feb [cited 2022 Jan 12];39(2):187–210. Available from: https://dx.doi.org/10.1016/j.ultrasmedbio.2012.09.002
3. Dietrich C, Averkiou M, Nielsen M, Barr R, Burns P, Calliada F, et al. How to perform Contrast-Enhanced Ultrasound (CEUS). Ultrasound International Open [Internet]. 2018 Jan [cited 2025 Jan 11];04(01):E2–15. Available from: https://dx.doi.org/10.1055%2Fs-0043-123931
4. Rafailidis V, Huang D, Yusuf GT, Sidhu PS. General principles and overview of vascular contrast-enhanced ultrasound (CEUS). Ultrasonography [Internet]. 2019 Jun 25 [cited 2025 Jan 11];39(1). Available from: https://dx.doi.org/10.14366/usg.19022
5. Yusuf GT, Fang C, Huang DY, Sellars ME, Deganello A, Sidhu PS. Endocavitary contrast enhanced ultrasound (CEUS): a novel problem solving technique. Insights into Imaging [Internet]. 2018 Mar 28 [cited 2019 Nov 11];9(3):303–11. Available from: https://dx.doi.org/10.1007/s13244-018-0601-x
6. Kim TK, Noh SY, Wilson SR, Kono Y, Piscaglia F, Jang HJ, et al. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system. Clinical and Molecular Hepatology [Internet]. 2017 Dec 25 [cited 2020 Oct 4];23(4):280–9. Available from: https://doi.org/10.3350/cmh.2017.0037
7. Sparchez Z, Mocan T, Craciun R, Sparchez M, Nolsøe C. Contrast enhancement for ultrasound-guided interventions: when to use it and what to expect? Ultrasonography [Internet]. 2022 Apr 1 [cited 2022 May 5];41(2):263–78. Available from: https://dx.doi.org/10.14366/usg.21207
8. Urraro F, Piscopo M, Giordano N, Russo GM, Gallo L, Magliocchetti S, et al. Diagnostic Value of Contrast-Enhanced Ultrasound in Differentiating Malignant from Benign Small Renal Masses After CT/MRI. Journal of Clinical Medicine [Internet]. 2024 Oct 29 [cited 2025 Jan 12];13(21):6478. Available from: https://dx.doi.org/10.3390/jcm13216478
9. Fu Y, Zhong J, Tan Y, Zheng T, Liu M, Wang G. Contrast-enhanced ultrasound for differentiating benign from malignant focal solid renal lesions in pediatric patients. Scientific Reports [Internet]. 2024 May 18 [cited 2025 Jan 12];14(1). Available from: https://dx.doi.org/10.1038/s41598-024-62496-z
10. Chang EH, Chong WK, Kasoji SK, Fielding JR, Altun E, Mullin LB, et al. Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease. BMC Nephrology [Internet]. 2017 Aug 9 [cited 2025 Jan 11];18(1). Available from: https://dx.doi.org/10.1186/s12882-017-0681-8
11. Tufano A, Antonelli L, Battista G, Flammia RS, Minelli R, Anceschi U, et al. Diagnostic Performance of Contrast-Enhanced Ultrasound in the Evaluation of Small Renal Masses: A Systematic Review and Meta-Analysis. Diagnostics [Internet]. 2022 Sep 25 [cited 2024 Feb 11];12(10):2310–0. Available from: https://dx.doi.org/10.3390/diagnostics12102310
12. Zhu J, Li N, Zhao P, Wang Y, Song Q, Song L, et al. Contrast-enhanced ultrasound (CEUS) of benign and malignant renal tumors: Distinguishing CEUS features differ with tumor size. Cancer Medicine. 2022 Sep 4;12(3):2551–9.
13. Piscaglia F, Lencioni R, Sagrini E, Pina CD, Cioni D, Vidili G, et al. Characterization of Focal Liver Lesions with Contrast-Enhanced Ultrasound. Ultrasound in Medicine and Biology [Internet]. 2010 Apr 1 [cited 2025 Jan 11];36(4):531–50. Available from: https://dx.doi.org/10.1016/j.ultrasmedbio.2010.01.004
14. Tufano A, Drudi FM, Angelini F, Polito E, Martino M, Granata A, et al. Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Renal Masses with Histopathological Validation—Results from a Prospective Single-Center Study. Diagnostics [Internet]. 2022 May 12 [cited 2025 Jan 11];12(5):1209. Available from: https://dx.doi.org/10.3390/diagnostics12051209
15. Zbroja M, Kuczyńska M, Drelich K, Mikos E, Zarajczyk A, Cheda M, et al. Contrast-Enhanced Ultrasound in the Diagnosis of Solid Renal Lesions. Journal of Clinical Medicine [Internet]. 2024 Jun 29 [cited 2025 Jan 11];13(13):3821–1. Available from: https://doi.org/10.3390/jcm13133821
16. Mauri G, Porazzi E, Cova L, Restelli U, Tondolo T, Bonfanti M, et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights into Imaging [Internet]. 2014 Feb 22 [cited 2025 Jan 11];5(2):209–16. Available from: https://dx.doi.org/10.1007/s13244-014-0315-7
17. Piscaglia F, Venturi A, Mancini M, Giangregorio F, Vidili G, Magnolfi F, et al. Diagnostic Features of Real-Time Contrast-Enhanced Ultrasound in Focal Nodular Hyperplasia of the Liver. Ultraschall in der Medizin – European Journal of Ultrasound [Internet]. 2009 Nov 25 [cited 2025 Jan 12];31(03):276–82. Available from: https://dx.doi.org/10.1055/s-0028-1109852
18. Marschner CA, Rübenthaler J, Froelich MF, Schwarze V, Clevert DA. Benefits of contrast-enhanced ultrasonography for interventional procedures. Ultrasonography [Internet]. 2021 Apr 1 [cited 2025 Feb 11];40(2):207–16. Available from: https://dx.doi.org/10.14366/usg.20083
19. Oh TH, Lee YH, Seo IY. Diagnostic Efficacy of Contrast-Enhanced Ultrasound for Small Renal Masses. Korean Journal of Urology [Internet]. 2014 [cited 2022 May 14];55(9):587. Available from: https://dx.doi.org/10.4111/kju.2014.55.9.587
20. Liu H, Cao H, Chen L, Fang L, Liu Y, Zhan J, et al. The quantitative evaluation of contrast-enhanced ultrasound in the differentiation of small renal cell carcinoma subtypes and angiomyolipoma. Quantitative Imaging in Medicine and Surgery [Internet]. 2022 Jan 1 [cited 2022 Dec 3];12(1):10618–10118. Available from: https://dx.doi.org/10.21037/qims-21-248
21. Tao L, Fan J, Zhan W, Li W, Lu J, Yang N, et al. Contrast-enhanced ultrasound manifestations of renal masses undetectable on conventional ultrasound. Frontiers in Oncology [Internet]. 2022 Jul 25 [cited 2023 Feb 25];12(1). Available from: https://dx.doi.org/10.3389/fonc.2022.943960
22. Granata A, Campo I, Lentini P, Pesce F, Gesualdo L, Basile A, et al. Role of Contrast-Enhanced Ultrasound (CEUS) in Native Kidney Pathology: Limits and Fields of Action. Diagnostics [Internet]. 2021 Jun 8 [cited 2022 May 6];11(6):1058. Available from: https://dx.doi.org/10.3390/diagnostics11061058
23. Cokkinos DD, Antypa EG, Skilakaki M, Kriketou D, Tavernaraki E, Piperopoulos PN. Contrast Enhanced Ultrasound of the Kidneys: What Is It Capable of? BioMed Research International [Internet]. 2013 [cited 2022 Dec 2];2013(1):595873. Available from: https://dx.doi.org/10.1155/2013/595873
24. 24.Lioznovs A, Radzina M, Saule L, Grinbergs PE, Lacis A. What Is the Added Value of Carotid CEUS in the Characterization of Atherosclerotic Plaque? Medicina [Internet]. 2024 Feb 23 [cited 2024 Aug 11];60(3):375–5. Available from: https://doi.org/10.3390/medicina60030375
25. Masino F, Eusebi L, Bertolotto M, Pizzileo SM, Pizzolorusso F, Sortino G, et al. Contrast-enhanced ultrasound in renal cystic lesions: an update. Journal of Medical Ultrasonics [Internet]. 2024 Aug 20 [cited 2025 Jan 11];51(4):635–47. Available from: https://dx.doi.org/10.1007/s10396-024-01489-x
26. Huang DY, Yusuf GT, Daneshi M, Ramnarine R, Deganello A, Sellars ME, et al. Contrast-enhanced ultrasound (CEUS) in abdominal intervention. Abdominal Radiology [Internet]. 2018 Feb 15 [cited 2025 Jan 11];43(4):960–76. Available from: https://dx.doi.org/10.1007/s00261-018-1473-8
27. Prada F, Mattei L, Del Bene M, Aiani L, Saini M, Casali C, et al. Intraoperative Cerebral Glioma Characterization with Contrast Enhanced Ultrasound. BioMed Research International [Internet]. 2014 Jan 1 [cited 2023 Aug 1];2014(1):1–9. Available from: http://dx.doi.org/10.1155/2014/484261